EVEREST-1 (NCT05736731) evaluates A2B530, targeting carcinoembryonic antigen (CEA) for pancreatic, lung, and colorectal cancers. Both programmes utilise the BASECAMP-1 pre-screening study ...
The current guidelines for post-curative treatment monitoring of CRC rely on a serial blood biomarker known as CEA (carcinoembryonic antigen) and CT imaging. Despite CEA testing being standard of ...
Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial Colorectal cancer (CRC) remains a major global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback